14shows ABR threshold shifts observed upon administration of a JNK inhibitor formulation to guinea pigs prior to cisplatin treatment
Alert systems based on toxic paracetamol levels are not representative, as the patient presented in the case had a subtherapeutic paracetamol level
The outcome is notable because FDA scientists' own analyses did not support easing restrictions on any of the four peptides considered Thursday
In certain instances, once exposure to an active agent (e.g., concentration in the endolymph or perilymph) reaches steady state, the concentration of an active agent in the endolymph or perilymph stays at or about the therapeutic dose for an extended period of time (e.g., one day, 2 days, 3 days, 4 days, 5 days, 6 days, 1 week, 3 weeks, 6 weeks, or 2 months)